Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation.

TitleProstate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation.
Publication TypeJournal Article
Year of Publication2020
AuthorsAwamlh BAl Hussein, Margolis DJ, Gross MD, Natarajan S, Priester A, Hectors S, Ma X, Mosquera JMiguel, Liao J, Hu JC
JournalUrology
Volume138
Pagination98-105
Date Published2020 Apr
ISSN1527-9995
Abstract

OBJECTIVE: To assess the qualitative and quantitative changes on prostate multiparametric magnetic resonance imaging (mpMRI) following partial gland ablation (PGA) with cryotherapy and correlate with histopathology.

METHODS: We used 3D Slicer to generate prostate models and segment ipsilateral (treated) and contralateral peripheral and transition zones in 10 men who underwent MRI/transrectal ultrasound fusion-guided PGA during 2017-2018. Pre- and post-PGA volumes of prostate segments were compared. Post-PGA mpMRI were categorized according to PI-RADS v2 and treatment response on mpMRI was assessed in a manner similar to the radiology evaluation framework following liver lesion ablation.

RESULTS: Median volume of ipsilateral peripheral and transition zones decreased from 10.9 mL and 13.0 mL to 7.2 mL and 10.8 mL (P = .005), respectively. Median volume of contralateral peripheral and transition zones also decreased from 12.1 mL and 12.5 mL to 9.9 mL to 10.4 mL (P = .005), respectively. Five men had clinically significant disease (Grade group ≥2) on post-PGA biopsy (3 within treatment field and 2 outside). Of the men with clinically significant prostate cancer, mpMRI revealed PI-RADS 3 lesions in 2. However, the treatment response framework did not detect residual disease.

CONCLUSION: PGA results in asymmetrical and significant reductions in prostate volume. Our results highlight the need for a separate assessment framework to enable standardization of the interpretation and reporting of post-PGA surveillance mpMRI. Moreover, our findings have significant implications for MRI-targeted surveillance biopsy following PGA with cryotherapy.

DOI10.1016/j.urology.2020.01.005
Alternate JournalUrology
PubMed ID31954170
Related Faculty: 
Juan Miguel Mosquera, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700